According to Article 1(20) of EU Directive 2001/83/EC on medicinal products for human use, the name of a pharmaceutical may be either an invented name not liableto be confused with the common name, or a common or scientific name accompanied by either a trademark or the name of the marketing authorisation holder. The directive further defines ‘common name’ as the international non-proprietary name (INN) recommended by the World HealthOrganisation, or, if no INN exists, as the usual common name.


Get unlimited access to all WTR content